Allogeneic mesenchymal stem cell therapy
Allogeneic mesenchymal stem cell therapy has been studied in 1 paper since 2016: none in people yet. No study of it in people or animals has been published yet. The newest paper, Mar 5, 2016: “Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized,…”.
1 paper studies itUpdated
Latest
Oncotarget
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
Study protocolInterventions